EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access

Risk of gynaecologic cancers in women with metabolic syndrome: A systematic review & meta-analysis

Indra Kundu, Denny John, Iqra Ansari, Keechilat Pavithran, Susan Idicula-Thomas

The Indian Journal of Medical Research · 10.10.2025 · 162 · 197-210

DOI: 10.25259/ijmr_588_2025 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Indian Journal of Medical Research, online erschienen am 10.10.2025. Verfasst von Indra Kundu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Informatics Center, ICMR- National Institute of Research in Reproductive and Child Health, Mumbai, Maharashtra, India. Hauptthemen laut MEDLINE: Metabolic Syndrome, Genital Neoplasms, Female, Ovarian Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & objectives Metabolic syndrome may be associated with the risk of gynaecological cancers. This systematic review aims to evaluate the risk of gynaecological cancers among women with metabolic syndrome.

Methods

Studies published in English using a search strategy across PubMed, Google Scholar, and Scopus were identified from the earliest available indexing of the respective databases up to September 12-14, 2023. After removing duplicates and conducting a detailed screening by two independent reviewers, 25 studies were identified. Critical appraisal was conducted using JBI checklists for case-control and cohort studies and AXIS checklist for cross-sectional studies. Data extraction was conducted for information pertaining to study design, participant demographics, definition of metabolic syndrome, reported summary measures and type of gynaecological cancer.

Results

Random effects models were employed separately for each study design, reported summary measures and the type of gynaecological cancers. In case-control, cross-sectional, and cohort studies, presence of metabolic syndrome was associated with uterine/endometrial cancer [odds ratio (OR) 1.99, P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeGenital Neoplasms, FemaleOvarian NeoplasmsHumansFemaleRisk FactorsEndometrial Neoplasms

Stichwörter der Autor:innen

Cervical cancerendometrial cancermetabolic syndromeovarian cancerriskvaginal cancer

Autor:innen und Institutionen

  • Department of Biomedical Informatics Center, ICMR- National Institute of Research in Reproductive and Child Health, Mumbai, Maharashtra, India.
  • Department of Allied Health Sciences, Faculty of Life and Allied Health Sciences, MS Ramaiah University of Applied Sciences, Bengaluru, Karnataka, India.
  • Department of Medical Oncology, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidhyapeetham, Kochi, Kerela, India.

Zitieren

APA

Kundu, I., John, D., Ansari, I., Pavithran, K., & Idicula-Thomas, S. (2025). Risk of gynaecologic cancers in women with metabolic syndrome: A systematic review & meta-analysis. The Indian Journal of Medical Research, 162, 197-210. https://doi.org/10.25259/ijmr_588_2025

Vancouver

Kundu I, John D, Ansari I, Pavithran K, Idicula-Thomas S. Risk of gynaecologic cancers in women with metabolic syndrome: A systematic review & meta-analysis. The Indian Journal of Medical Research. 2025;162:197-210. doi:10.25259/ijmr_588_2025

BibTeX
@article{Kundu2025,
  author = {Kundu, Indra and John, Denny and Ansari, Iqra and Pavithran, Keechilat and Idicula-Thomas, Susan},
  title = {Risk of gynaecologic cancers in women with metabolic syndrome: A systematic review & meta-analysis},
  journal = {The Indian Journal of Medical Research},
  year = {2025},
  volume = {162},
  pages = {197--210},
  doi = {10.25259/ijmr_588_2025}
}
Kostenlos starten →